141 related articles for article (PubMed ID: 38074824)
1. Association of ACP5 with the tumor immune microenvironment and its role in cell proliferation and metastasis in pancreatic cancer.
Shen J; Shi M; Song A; Ming Y; Zhu X; Ruan Y; Zhang T; Zhou G
Am J Transl Res; 2023; 15(11):6437-6450. PubMed ID: 38074824
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
Huang S; Hou Y; Hu M; Hu J; Liu X
BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
[TBL] [Abstract][Full Text] [Related]
3. EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway.
Xu J; Zhang W
Cancer Cell Int; 2021 Oct; 21(1):521. PubMed ID: 34627255
[TBL] [Abstract][Full Text] [Related]
4.
Ren L; Li Y; Feng Y; Zhang Z; Yang H; Li M
Transl Cancer Res; 2024 Mar; 13(3):1443-1457. PubMed ID: 38617512
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of HMGB3 and its prognostic value in breast cancer.
Zhou X; Zhang Q; Liang G; Liang X; Luo B
Front Oncol; 2022; 12():1048921. PubMed ID: 36620553
[TBL] [Abstract][Full Text] [Related]
6. The EMT-Related Genes GALNT3 and OAS1 are Associated with Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma.
Luo D; Fang M; Shao L; Wang J; Liang Y; Chen M; Gui X; Yan J; Wang W; Yu L; Fan X; Wu Q
Front Biosci (Landmark Ed); 2023 Oct; 28(10):271. PubMed ID: 37919050
[TBL] [Abstract][Full Text] [Related]
7. CYP26A1 Is a Novel Cancer Biomarker of Pancreatic Carcinoma: Evidence from Integration Analysis and
Yu Y; Wang Y; Zou Y; Yu Y
Dis Markers; 2022; 2022():5286820. PubMed ID: 35707714
[TBL] [Abstract][Full Text] [Related]
8. RANK promotes colorectal cancer migration and invasion by activating the Ca
Liang Q; Wang Y; Lu Y; Zhu Q; Xie W; Tang N; Huang L; An T; Zhang D; Yan A; Liu S; Ye L; Zhu C
Cell Death Dis; 2021 Apr; 12(4):336. PubMed ID: 33795653
[TBL] [Abstract][Full Text] [Related]
9. RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma.
Peng H; Du X; Zhang Y
Front Mol Biosci; 2022; 9():898567. PubMed ID: 35720121
[No Abstract] [Full Text] [Related]
10. Kockdown of ACP5 inhibits hepatocellular carcinoma progression.
Shi R; Liu T; Liu Z; Yang L; Shi Y; Zhang Y
Am J Transl Res; 2020; 12(5):1904-1912. PubMed ID: 32509186
[TBL] [Abstract][Full Text] [Related]
11. The downregulation of fibrinogen-like protein 1 inhibits the proliferation of lung adenocarcinoma via regulating
Tang XY; Xiong YL; Shi AP; Sun Y; Han Q; Lv Y; Shi XG; Frattini M; Malhotra J; Zheng KF; Liu YJ; Jiang T; Ma N; Zhao JB
Transl Lung Cancer Res; 2022 Mar; 11(3):404-419. PubMed ID: 35399566
[TBL] [Abstract][Full Text] [Related]
12. A systematic analysis of
Jiang Y; Wang X; Li L; He J; Jin Q; Long D; Liu C; Zhou W; Liu K
Front Genet; 2022; 13():926943. PubMed ID: 35991552
[No Abstract] [Full Text] [Related]
13. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L
Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642
[TBL] [Abstract][Full Text] [Related]
14. Overexpressed ACP5 has prognostic value in colorectal cancer and promotes cell proliferation and tumorigenesis via FAK/PI3K/AKT signaling pathway.
Bian ZQ; Luo Y; Guo F; Huang YZ; Zhong M; Cao H
Am J Cancer Res; 2019; 9(1):22-35. PubMed ID: 30755809
[TBL] [Abstract][Full Text] [Related]
15. NcRNA-Mediated High Expression of
Jiang X; Tang L; Yuan Y; Wang J; Zhang D; Qian K; Cho WC; Duan L
Front Oncol; 2022; 12():846536. PubMed ID: 35311097
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer.
Du J; Chen Y; Liu G; Zeng Q; Zhou N; Du D
Pathol Res Pract; 2023 Mar; 243():154374. PubMed ID: 36801507
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.
Wei Q; Miao T; Zhang P; Jiang B; Yan H
Front Genet; 2022; 13():984575. PubMed ID: 36159963
[No Abstract] [Full Text] [Related]
18. SGLT-2 as a potential target in pancreatic cancer: the preliminary clue from The Cancer Genome Atlas data.
Qiang W; Lei Y; Yuan L; Yuan J; Zhang J; Shan Y; Tian H; Shi B; Guo H
J Gastrointest Oncol; 2022 Oct; 13(5):2539-2552. PubMed ID: 36388652
[TBL] [Abstract][Full Text] [Related]
19. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors.
Li Y; Fu W; Geng Z; Song Y; Yang X; He T; Wu J; Wang B
PeerJ; 2022; 10():e14432. PubMed ID: 36518297
[TBL] [Abstract][Full Text] [Related]
20. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.
Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y
BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
